MEDIGENE Trademark

Trademark Overview


On Wednesday, March 20, 2019, a trademark application was filed for MEDIGENE with the United States Patent and Trademark Office. The USPTO has given the MEDIGENE trademark a serial number of 88347854. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 11, 2022. This trademark is owned by Medigene AG. The MEDIGENE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical and veterinary preparations, namely, cellular preparations for the treatment of tumours/neoplastic diseases, hematological tumors, more specifically leukemias or lymphomkas, solid tumors; Pharmaceutical T-cell preparations and dendritic cell preparations for the treatment of cancer and use in immunotherapy; medical compositions in the nature of pharmaceutical preparations for the treatment of hematological and solid tumors, tumor precursors; Test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of soluble T-cell receptors; test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of genetically modified cells; Test kits for diagnostic preparations for medical purposes for determining the type/existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors a...

Cell analyses in the nature of medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto; Individualized medicine in the nature of medical services; medical services specifically, development of treatment plans for the treatment of tumors and/or neoplastic diseases, hematopoietic tumors, solid tumors; physical therapy adapted for individual patients

Services in molecular biology, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; Development of test methods and test kits; Development of adoptive T cell therapy; Development of DC vaccines; Development of cellular tumour therapy; Development of tumour markers; Development of diagnostic and therapeutic antibodies
medigene

General Information


Serial Number88347854
Word MarkMEDIGENE
Filing DateWednesday, March 20, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements


Description of MarkThe mark consists of the wording "MEDIGENE" in stylized script, where the letter "I" is comprised of two oval shapes.
Goods and ServicesPharmaceutical and veterinary preparations, namely, cellular preparations for the treatment of tumours/neoplastic diseases, hematological tumors, more specifically leukemias or lymphomkas, solid tumors; Pharmaceutical T-cell preparations and dendritic cell preparations for the treatment of cancer and use in immunotherapy; medical compositions in the nature of pharmaceutical preparations for the treatment of hematological and solid tumors, tumor precursors; Test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of soluble T-cell receptors; test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of genetically modified cells; Test kits for diagnostic preparations for medical purposes for determining the type/existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; Diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCell analyses in the nature of medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto; Individualized medicine in the nature of medical services; medical services specifically, development of treatment plans for the treatment of tumors and/or neoplastic diseases, hematopoietic tumors, solid tumors; physical therapy adapted for individual patients
Goods and ServicesServices in molecular biology, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; Development of test methods and test kits; Development of adoptive T cell therapy; Development of DC vaccines; Development of cellular tumour therapy; Development of tumour markers; Development of diagnostic and therapeutic antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 7, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 7, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 7, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedigene AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPlanegg-Martinsried 82152
DE

Party NameMedigene AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPlanegg-Martinsried 82152
DE

Trademark Events


Event DateEvent Description
Monday, April 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 14, 2021SOU EXTENSION 1 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 1 FILED
Tuesday, September 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 3, 2020EXPARTE APPEAL TERMINATED
Thursday, December 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 3, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Saturday, September 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 31, 2020NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 31, 2020ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 31, 2020ACTION CONTINUING FINAL - COMPLETED
Tuesday, August 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 3, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 3, 2020EX PARTE APPEAL-INSTITUTED
Monday, August 3, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, August 3, 2020EXPARTE APPEAL RECEIVED AT TTAB
Monday, February 3, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 3, 2020FINAL REFUSAL E-MAILED
Monday, February 3, 2020FINAL REFUSAL WRITTEN
Monday, December 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 30, 2019ASSIGNED TO LIE
Monday, December 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 7, 2019NON-FINAL ACTION E-MAILED
Friday, June 7, 2019NON-FINAL ACTION WRITTEN
Friday, May 31, 2019ASSIGNED TO EXAMINER
Tuesday, April 9, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, April 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 23, 2019NEW APPLICATION ENTERED